Skip to main content
Market intelligence
LUNGHealthcare

Pulmonx Corp insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 1, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 1, 2026Srikanth RadhakrishnanChief Science & Techn. OfficerSale14,245$2.26$32,194
Sep 1, 2026Glendon E. French IiiPresident and CEOSale41,882$2.26$94,653
Sep 1, 2026Geoffrey Beran RoseChief Commercial OfficerSale7,879$2.26$17,807